University of Ioannina
Βιολογικές εφαρμογές νανοϋλικών για τη διάγνωση και αντιμετώπιση διαταραχών του μεταβολισμού της γλυκόζης
Abstract
dc:descriptionDiabetes Mellitus (DM) is a chronic metabolic disorder characterized by impaired glucose homeostatic regulation in the body. Over the last decades, DM has reached epidemic levels worldwide. According to the International Diabetes Federation it is estimated that approximately 538 million adults are living with diabetes and this number is projected to rise to 783 million by 2045. DM has become one of the major public health issues, significantly impacting the socio- economic development of each country. The evolution of Nanotechnology brought hope for achieving effective management of DM. The development of continuous glucose monitoring systems as well as insulin pumps, significantly reduced the episodes of hypo- and hyper- glycemia and improved the quality of life of diabetics. However, there is still room for improvement, and efforts are now being made to develop new systems for detecting glucose levels and administering therapeutic treatment. Specifically, research aims at developing non-invasive “closed- loop” systems for diabetes management, which will not only provide continuous glucose monitoring but also release the appropriate therapeutic agent when it is necessary. These systems will significantly improve the quality of life for those suffering from the disease, as they will offer more effective glucose control, reduced drug dosage, better patient compliance, and improved treatment control. The development of “closed- loop” systems require the creation of innovative non-invasive biosensors for the detection of glucose in biological fluids other than blood (e.g. in sweat) and nanocarriers for the automated administration of therapeutic treatment, by alternative routes, when needed. For this reason, the synthesis of more efficient and more biocompatible nanomaterials is necessary. Of all nanomaterials, graphene stood out early in biomedical applications, due to its excellent electrochemical properties. Its unique characteristics make it an ideal candidate for the development of high precision biosensors. In fact, graphene biosensors are state-of-the-art compared to conventional sensors in terms of resolution and sensitivity. The only reason why graphene has not completely taken over the world of medical applications, is the difficulty in producing high-quality graphene in large-scale, at a low cost and in an environmentally friendly way. In recent years, “green” chemistry techniques made possible the biological exfoliation of graphene from graphite without the use of toxic solvents. However, the biocompatibility of these structures with human cells and tissues has not been explored yet. The primary objective of this PhD thesis was to investigate whether the "green" exfoliation of graphite leads to the synthesis of more biocompatible nanomaterials compared to conventional methods. As the functional modification of nanomaterials affects both their characteristics and their toxicity, three different graphene- based structures were tested in vitro: graphene, nitrogen-doped (N-Doped) graphene and nitrate- bonded graphene. The three nanomaterials were synthesized by two different methods involving the use of chemical or biological solvents. It is known that the effects of nanomaterials differ in each cell type, so the toxicity of graphene nanomaterials was tested in three different cell lines (NIH/3T3 fibroblasts, HaCaT keratinocytes and THP-1 differentiated macrophages), which together constitute a skin model. Using modern methods, the immediate or long-term toxicity of nanomaterials to cells, the possible induction of cell death or oxidative stress, their effect on the cell cycle and their interaction with molecules that play an important role in critical signaling pathways of inflammation, were examined. Thorough cytotoxicity assessment proved that “green” synthesis of graphene maintains its uniqueness while limiting its negative effects on cells. Therefore, “green” graphene becomes an ideal candidate for biomedical applications, including the development of high- precision biosensors for non- invasive glucose detection. A second aim of this thesis was to investigate the effectiveness of innovative nanoemulsions to act as nanocarriers for transdermal release of commercial hypoglycemic drugs. In an in vivo model, it was shown that dapagliflozin, a common drug for DM, through nanoemulsions successfully penetrates the skin of laboratory animals and exerts its strong hypoglycemic effect without causing toxic reactions in the body. Combined, the development of innovative, non- toxic, non- invasive glucose sensors with “green” graphene and the use of nanoemulsions as nanocarriers for the transdermal delivery of antidiabetic drugs, may lead to the design of a fully automated “closed” system for the management of DM. This system will significantly improve the quality of life of the ever- increasing patients.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papanikolaou, Eirini
- Παπανικολάου, Ειρήνη
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/56598